Next Article in Journal
Signal Transduction of Platelet-Induced Liver Regeneration and Decrease of Liver Fibrosis
Previous Article in Journal
Tug of War between Survival and Death: Exploring ATM Function in Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 15
Issue 4
10.3390/ijms15045410
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Int. J. Mol. Sci. 2013, 14(9), 18899-18924.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kikuchi, K., et al., Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke. Int. J. Mol. Sci. 2013, 14, 18899–18924.

by
Kiyoshi Kikuchi
1,2,3,
Salunya Tancharoen
1,
Takashi Ito
4,
Yoko Morimoto-Yamashita
5,
Naoki Miura
6,
Ko-ichi Kawahara
7,
Ikuro Maruyama
4,
Yoshinaka Murai
2 and
Eiichiro Tanaka
2,*
1
Department of Pharmacology, Faculty of Dentistry, Mahidol University, 6 Yothe Road, Rajthevee, Bangkok 10400, Thailand
2
Division of Brain Science, Department of Physiology, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan
3
Department of Neurosurgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan
4
Department of Systems Biology in Thromboregulation, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
5
Department of Restorative Dentistry and Endodontology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
6
Laboratory of Diagnostic Imaging, Department of Veterinary Science, Faculty of Agriculture, Kagoshima University, 1-21-24 Korimoto, Kagoshima 890-0065, Japan
7
Laboratory of Functional Foods, Department of Biomedical Engineering Osaka Institute of Technology, 5-16-1 Omiya, Asahi Ward, Osaka 535-8585, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2014, 15(4), 5410-5411; https://doi.org/10.3390/ijms15045410
Submission received: 3 March 2014 / Accepted: 3 March 2014 / Published: 27 March 2014
Versions Notes
The original version of the paper [1] reports that “This ACTIVE I study was supported by Pfizer” (Page 18905). However, the sponsors of the ACTIVE I study were actually Bristol-Myers Squibb and Sanofi-Aventis rather than Pfizer. Therefore, we would like to correct the wording to read: “This ACTIVE I study was supported by Bristol-Myers Squibb and Sanofi-Aventis”. The authors apologize for any inconvenience this may have caused to the readers of this journal.

Reference

  1. Kikuchi, K.; Tancharoen, S.; Ito, T.; Morimoto-Yamashita, Y.; Miura, N.; Kawahara, K.-I.; Maruyama, I.; Murai, Y.; Tanaka, E. Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke. Int. J. Mol. Sci 2013, 14, 18899–18924. [Google Scholar]

Share and Cite

MDPI and ACS Style

Kikuchi, K.; Tancharoen, S.; Ito, T.; Morimoto-Yamashita, Y.; Miura, N.; Kawahara, K.-i.; Maruyama, I.; Murai, Y.; Tanaka, E. Correction: Kikuchi, K., et al., Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke. Int. J. Mol. Sci. 2013, 14, 18899–18924. Int. J. Mol. Sci. 2014, 15, 5410-5411. https://doi.org/10.3390/ijms15045410

AMA Style

Kikuchi K, Tancharoen S, Ito T, Morimoto-Yamashita Y, Miura N, Kawahara K-i, Maruyama I, Murai Y, Tanaka E. Correction: Kikuchi, K., et al., Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke. Int. J. Mol. Sci. 2013, 14, 18899–18924. International Journal of Molecular Sciences. 2014; 15(4):5410-5411. https://doi.org/10.3390/ijms15045410

Chicago/Turabian Style

Kikuchi, Kiyoshi, Salunya Tancharoen, Takashi Ito, Yoko Morimoto-Yamashita, Naoki Miura, Ko-ichi Kawahara, Ikuro Maruyama, Yoshinaka Murai, and Eiichiro Tanaka. 2014. "Correction: Kikuchi, K., et al., Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke. Int. J. Mol. Sci. 2013, 14, 18899–18924." International Journal of Molecular Sciences 15, no. 4: 5410-5411. https://doi.org/10.3390/ijms15045410

Article Metrics

Back to TopTop